6.1 Oral Nutrition Supplements & Micronutrient Therapy

6.1 Oral Nutrition Supplements & Micronutrient Therapy

Oral nutrition supplements (ONS) and targeted micronutrient therapies are foundational non-invasive interventions to reverse protein-energy malnutrition, arrest sarcopenia, and support tissue healing in older adults. Age-associated anorexia of aging, chronic disease, blunted gustatory and olfactory acuity, and early satiety frequently prevent older adults from meeting metabolic demands through conventional food alone. Consider ONS when accepted food is insufficient and expected benefit fits the care plan; no single 75% threshold applies to every setting. Assess micronutrient replacement separately.

---

1. Classification and Formulation of Oral Nutrition Supplements

The following are illustrative product categories, not standardized formulations or mandatory prescriptions. Products differ in density, protein, electrolytes, and ingredients; verify the actual label and assessed indication:

Exam Tip: While pulmonary-specific formulas theoretically lower carbon dioxide production by reducing the respiratory quotient (RQ), a lower respiratory quotient does not establish better clinical outcomes or justify routine use in stable COPD. Avoid overfeeding and assess tolerance and overall adequacy. High-fat content may worsen delayed gastric emptying in frail older adults.

---

2. Administration Timing and the Med-Pass Strategy

The clinical efficacy of ONS depends entirely on patient compliance and the prevention of meal displacement:

Timing, Label Content, and Actual Intake

ONS may be offered between meals or in smaller doses when a large serving displaces accepted food. Some residents consume supplements best with a meal; choose timing from observed intake rather than a universal 30–50% displacement rule.

A med-pass protocol can support delivery and intake recording, but adherence, cost, and effects on meals vary. Three or four 60–90-mL doses of a 2-kcal/mL product offer 360–720 kcal daily; protein depends on the label and actual consumption. Review drug-food timing and swallowing precautions with the pharmacist and SLP.

ESPEN recommends that ONS prescribed to an older person with malnutrition or risk should provide at least 400 kcal and 30 g protein daily, generally for at least one month, with regular assessment of consumption and benefit. Apply the overall plan to illness, renal function, tolerance, and goals rather than assuming every product or dose meets this recommendation.

---

3. Essential Micronutrient Supplementation in Geriatrics

Age-associated organ senescence, reduced solar exposure, and gastric hypochlorhydria place older adults at high risk for micronutrient deficits:

Vitamin D (Cholecalciferol)

• Physiological Vulnerability: Reduced cutaneous production, limited sunlight or intake, malabsorption, and kidney disease can increase risk. Age alone does not establish deficiency.
• Vitamin D Intake: The RDA is 600 IU/day through age 70 and 800 IU/day from age 71. Treat deficiency according to clinical circumstances. Current guidance does not establish a universal serum target of at least 30 ng/mL for all older adults; selected bone disorders may use different clinical targets.

Calcium

• Calcium Intake: The RDA is 1,200 mg/day for women age 51+ and all adults age 71+; men age 51–70 need 1,000 mg/day. Count food and supplements together.
• Formulation Selection: Calcium citrate is less acid-dependent and can be taken without food. Carbonate absorption improves with meals, including in low-acid conditions. Select the product from intake, indication, tolerance, medication timing, and clinical context rather than preferring citrate for every older adult.
• Divided Dosing: Fractional absorption is best at supplement doses of 500 mg elemental calcium or less; it is not a hard absorption cutoff. Split larger amounts and review total intake, kidney status, and stone risk. The upper intake level is 2,000 mg/day from age 51, unless medical treatment requires a supervised exception.

Vitamin B12 (Cobalamin)

• Malabsorption Etiology: Atrophic gastritis and acid suppression can impair release of food-bound B12. Pernicious anemia impairs intrinsic factor, while metformin can interfere with B12 absorption through other mechanisms; metformin does not abolish gastric acid secretion.
• B12: Crystalline B12 avoids the need to release it from food protein. It can use intrinsic-factor-mediated absorption when that pathway is intact; high oral doses also have a small passive absorption fraction. Fortified foods may help meet the 2.4-mcg RDA, while confirmed deficiency requires a clinician-selected oral or parenteral regimen, especially with neurological symptoms.

---

4. Pressure Injury Nutrition

The current international pressure-injury guideline supports nutrition screening, comprehensive assessment, and individualized intervention for malnutrition or risk. Energy and protein prescriptions depend on body composition, wound burden, illness, renal function, activity, and goals.

Older 2019 guideline benchmarks of 30–35 kcal/kg/day and 1.25–1.5 g protein/kg/day remain useful reference values for adults with pressure injuries who are malnourished or at risk, but they are not automatic prescriptions for every stage or body size. Evaluate kidney function and intake before selecting a higher protein amount.

A complete energy/protein plan takes priority over isolated amino-acid products. Arginine-enriched formulas with protein and micronutrients can be considered for selected patients; current recommendations are conditional and do not mandate glutamine for every pressure injury. Vitamin C and zinc have physiological roles in collagen and tissue repair, but this does not prove that high doses help someone who is replete.

Correct suspected or confirmed deficiencies under clinical supervision. Count elemental zinc rather than salt weight; prolonged high intake can cause copper deficiency, anemia, and neutropenia. The adult zinc upper intake level is 40 mg/day; medically supervised treatment may exceed it, with a defined indication, duration, and follow-up rather than a universal 2–3-week rule.

5. Clinical Case Scenario

An 83-year-old female in long-term care with Stage 3 chronic kidney disease (eGFR $42\text{ mL/min/1.73 m}^2$), severe osteoarthritis on omeprazole, and a non-healing sacral Stage 3 pressure injury consumes 50% of meal trays. Her baseline weight is 54 kg.

• Nutrient Targets: Energy $32\text{ kcal/kg} = 1,728\text{ kcal/day}$; Protein $1.3\text{ g/kg} = 70\text{ g/day}$.
• Intervention Plan: The RDN coordinates an individualized energy/protein plan with the kidney-care team and selects a label-verified supplement, assessing whether a specialized wound formula is appropriate. The team assesses total calcium intake and B12 status. If supplementation is indicated, calcium citrate can fill the dietary gap; confirmed B12 deficiency receives a clinician-selected regimen. Omeprazole use alone does not justify automatic 1,000-mg calcium and high-dose B12 orders. Zinc replacement is considered only if deficiency or inadequate intake is identified, with follow-up of dose, duration, and copper risk.

---

6. Decisions to Practice

• Read product labels and record intake; concentration alone does not establish protein delivery.
• Prefer a practical calcium form and divided dosing after accounting for dietary calcium.
• Distinguish preventive micronutrient intake from treatment of deficiency.
• Individualize pressure-injury targets and avoid routine high-dose zinc or unproven single-substrate prescriptions.

Primary source check

NIH vitamin D, calcium, B12 and zinc fact sheets, checked October 13, 2026.

Current International Guideline nutrition chapter, checked October 13, 2026.